28th September 2016
BD (Becton, Dickinson and Company), a leading global medical technology company announced a €36 million ($40 million) investment in new equipment to expand its production of BD PosiFlush™ syringes and create up to 20 additional jobs in Drogheda.
The company is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.
BD produces BD PosiFlush syringes and safety components for insulin injection at its Drogheda facility.
The investment facilitates the installation of two new production lines at the Drogheda plant. The first new manufacturing line has just commenced production and work has commenced on the second line.
Welcoming the investment, Minister Mary Mitchell O'Connor said ' I am delighted to be here in Drogheda this morning for this exciting announcement. Becton Dickinson have provided employment in this town for over 50 years and the new investment and additional jobs are a great boost.
‘This project builds on Ireland's expertise in medical devices and I am very pleased to see the benefits for a regional location, which follows our recently launched Action Plan for Jobs for this region.'
Mr Liam Dillon, BD Medical Plant Manager said that the additional and ongoing investment in the Drogheda facility demonstrates the company’s long term commitment to the 130 people working at the plant, the local community and Ireland.
“We are delighted that BD has invested €36 million ($40 million) on two new production lines in Drogheda. This investment will create an additional 20 jobs at the plant.
It will also allow us to expand the production of BD PosiFlush syringes, which are used in hospitals and medical centres throughout the world. Our team here in Drogheda will continue to manufacture high-quality products that contribute to the health and well-being of patients worldwide,” he said.
Commenting on the announcement Martin Shanahan, CEO, IDA Ireland said “Today’s announcement that Becton Dickinson is to create an additional 20 jobs and invest €36m at their Drogheda plant is a significant boost for the local economy of the North East region. This investment demonstrates the company’s long term commitment to Ireland and builds on its 50-year history in Drogheda.”
Becton Dickinson was one of the first medical device companies to locate in Ireland in 1964. It currently employs 130 people at the plant.
BD was the first international company to be funded when it set up in Drogheda on the Donore Road in 1964. Since then thousands of local people have been employed at the facility and billions of syringes and medical devices have been produced.
END
About BD
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.
David Curtin & Co
Public Relations
+353 1 8209466 (office)
+353 (0) 86 28 32 123
Email: David@Curtin.ie
Back to Department News